Payal Arya, PhD, is a Post-Doctoral Fellow at the Center for Integration of Science and Industry at Bentley University. She obtained her PhD in Biology from the Indian °ËØÔ±¬ÁÏ of Science Education and Research (IISER), Pune and her MS in Biotechnology from the University of Pune. During her graduate studies, Dr. Arya investigated protein interactions during DNA damage. As a National °ËØÔ±¬ÁÏs of Health (NIH) supported Post-Doctoral Fellow in the Neuroscience Department at Wellesley College, she managed multiple projects on understanding vocal learning in songbirds guided by early exposure to a father’s song. Dr. Arya studied acquisition of multiple auditory representations of father songs in birds using functional magnetic resonance imaging (fMRI), further developing songbirds as an animal model for the phonetics of human bilingualism. Starting at Bentley University in August 2023, her current research focuses on diverse business models for pharmaceutical innovation.
Payal Arya
By this expert
The Global Pharmaceutical Industry Isn’t Investing in Products for the Greatest Burden of Human Disease - Are Non-Profits a Solution?
Programs for expedited review may be preferentially reducing the development costs for conditions with lesser disease burden, potentially making investments in addressing the most significant disease burdens even less appealing and exacerbating the market failure further.